The role of virus biological phenotype in human immunodeficiency virus pathogenesis

AIDS Reviews

Volumn 3, Issue 3, 2001, Pages 157-168

  Fenyo E M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Co receptors; HIV; HIV 2; Pathogenesis; SIV; Subtypes; Tropism

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; LAMIVUDINE; VIRUS RECEPTOR; ZALCITABINE; ZIDOVUDINE;

ADULT; CHILD; DISEASE MODEL; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MACROPHAGE; NONHUMAN; PHENOTYPE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VIRUS GENOME; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 0035203305     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
2. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates
3. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
4. Biologic features of HIV-1 that correlate with virulence in the host
5. Naturally occurring HIV-1 isolates with differences in replicative capacity are distinguished by in situ hybridization of infected cells
6. Isolate-specific neutralizing antibodies in patients with progressive HIV-1 related disease
7. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates
8. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay
9. T-lymphocyte T4 molecule behaves as the receptor for human retroviral LAV
10. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
11. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
12. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells
13. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus
14. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
15. Identification of a major co-receptor for primary isolates of HIV-1
16. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
17. Chemokine receptors and their role in inflammation and infectious diseases
18. Co-receptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
19. A new classification for HIV-1
20. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
21. Chemokines and their receptors in lymphocyte traffic and HIV infection
22. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
23. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5
24. Expression cloning of new receptors used by simian and human immunodeficiency viruses
25. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
26. Development and standardisation of a cell line-based neutralisation assay for primary HIV-1 isolates
27. Quantitative evaluation of HIV-1 co-receptor use in the GHOST(3) cell assay
28. Co-receptor usage of sequential isolates from cynomolgus monkeys experimentally infected with simian immunodeficiency virus (SIVsm)
29. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
30. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS
31. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection
32. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
33. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
34. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV- suppressive factors produced by CD8+ T cells
35. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates
36. The biological phenotype of HIV-1 is usually retained during and after sexual transmission
37. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users
38. Change of coreceptor use appears after immune dysfunction is established in children infected with different HIV-1 subtypes
39. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
40. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals
41. HIV does not replicate in naïve CD4 T cells stimulated with CD3/CD28
42. Both memory and CD45RA+/CD62L+ naïve CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals
43. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
44. In vivo HIV-1 infection of CD45RA+ CD4+T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline
45. Infection of the CD45RA+ (naïve) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo
46. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation
47. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
48. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
49. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains
50. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
51. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope
52. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes
53. Host-pathogen interactions: The attributes of virulence
54. HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics. Workshop Report from the European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/AIDS
55. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
56. HIV-1 nomenclature proposal
57. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
58. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
59. Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia
60. A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure
61. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS
62. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India
63. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses
64. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants
65. Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C
66. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes
67. Occurrence of additional NF-kappaB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates
68. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function
69. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
70. Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia
71. Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents
72. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS
73. In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection
74. Immune activation is a dominant factor in the pathogenesis of African AIDS
75. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection
76. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: Relevance to AIDS in Africa
77. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
78. Macrophage tropism: Fact or fiction?
79. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages
80. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: Two distinct mechanisms of HIV-1 dual tropism
81. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture
82. CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages
83. Chemokine signaling and HIV-1 fusion mediated by macrophage CXCR4: Implications for target cell tropism
84. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates
85. CXCR-4 is expressed by primary macrophages and supports CCR5- independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1
86. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection
87. The kinetics of human immunodeficiency virus reverse transcription are slower in primary human macrophages than in a lymphoid cell line
88. Biological characterization of infectious molecular clones derived from a human immunodeficiency virus type-1 isolate with rapid/high replicative capacity
89. HIV-1 Env glycoproteins from two series of primary isolates: Replication phenotype and immunogenicity
90. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1
91. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
92. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses
93. Chemokine receptor regulation and HIV type 1 tropism in monocyte- macrophages
94. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
95. HIV-2-infected patients survive longer than HIV-1-infected patients
96. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
97. Slower heterosexual spread of HIV-2 than HIV-1
98. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4
99. Replicative and cytopathic characteristics of HIV-2 and severity of infection
100. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency
101. CCR5 or CXCR4 are required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates
102. Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm)
103. Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus
104. Simian immunodeficiency virus as a model of human HIV disease
105. G protein-coupled receptors in HIV and SIV entry: New perspectives on lentivirus-host interactions and on the utility of animal models
106. Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis
107. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
108. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
109. The antigenic structure of the HIV gp120 envelope glycoprotein
110. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
111. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
112. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
113. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: Phenotypic and genotypic characteristics. WHO network for HIV isolation and characterization
114. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D
115. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
116. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
117. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains
118. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
119. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
120. Biological determinants of HIV infection: Studies of viral evolution during disease progression in children and adults